The most likely curb on Trump’s tariff proclivities would be a sustained fall in stock prices. U.S. trade policy has been on ...
The Trade Desk (NASDAQ: TTD) has a reputation for beating expectations, which worked against it in the latest investor update ...
See our picks of the best free stock trading apps with no commission fees, user-friendly interfaces, and valuable research ...
Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...
Shares of The Trade Desk (TTD) have collapsed and are down 26% after the digital content and online advertising company ...
Ascendis Pharma beat Q4 earnings and revenue estimates, driven by a $100M Novo Nordisk deal and Yorvipath's EU launch.
Traders were on guard after Federal Reserve Chair Jerome Powell said on Tuesday that the central bank is in no hurry to lower ...
Neurocrine Biosciences Inc. (NASDAQ:NBIX) reported fourth-quarter adjusted EPS of $1.69, higher than the $1.54 reported a ...
Regarding market opportunities in the semiconductor industry, Intel (INTC) no longer commands the social cachet it once did ...
Despite challenges like avian flu and GLP-1s, Tyson's protein products remain essential, especially for those on exercise ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results